📣 Great to see this fabulous group attending the first event for 2026 organised by the @saigenci.bsky.social EMCR Committee and welcoming postdocs, students and RAs. A great opportunity to network and share ideas on supporting our community! ☕👏 @acepigenetics.bsky.social
📣Read about @saigenci.bsky.social Director, @chrissweens1.bsky.social, discussing advancements in treatment options for prostate cancer at @ascocancer.bsky.social GU Cancers Symposium 2026 in @pharmacytimes.bsky.social at www.pharmacytimes.com/view/a-new-t...
Spatial transcriptomics methods can struggle to scale on large datasets, or miss biological structure. Nora Liu @saigenci.bsky.social introduces DOMINO, a diffusion optimised contrastive learning framework for spatial domain detection, an accurate and scalable ST method.
Very pleased to share our latest published work on the role of the innate immune inflammasome adaptor ASC in promoting pancreatic cancer. Thanks to all in our multinational team!
pubmed.ncbi.nlm.nih.gov/41654528/
@saigenci.bsky.social
@natcomms.nature.com
@saigenci.bsky.social is pleased to be part of the team, led by @petermaccc.bsky.social, awarded $5m from PCFA. @katmorel.bsky.social will bring her expertise to the project team, an extension of "The Daisy Project" led by @chrissweens1.bsky.social See more bit.ly/45PoNyy bit.ly/4alvFW1
📣Welcome to our Ainsworth Fellows in the TII program @saigenci.bsky.social, researching the role of inflammation in lung and upper gastrointestinal cancers. Grateful for the generous support of the Ainsworth Foundation. Drs Tamsin Lannagan, Eun-Jung In, Georgette Radford, Rhynelle Dmello. 🧪🔬👏
As part of the transition to Adelaide University, this page now represents @saigenci.bsky.social at Adelaide University. Thank you for following and supporting us on our journey under the University of Adelaide. Follow @AdelaideUni for university-wide updates and to explore what’s ahead.
📣 The University of Adelaide and @saigenci.bsky.social were proud sponsors of the Australian Ubiquitin Summit 2025, held 16-20 November in Lorne, Victoria bringing together leading scientists, clinicians and industry innovators to explore ubiquitin biology and targeted protein degradation (TPD). 🧪🔬👏
📣Kicking off @saigenci.bsky.social's 2025/26 summer research program with a morning tea celebrating the arrival of this year's students. An event filled with conversation and connection as students met each other, engaged with supervisors and SAiGENCI summer student alumni.🎉
Mechanistic modelling with ODEs and Virtual Cell Models with foundational models this morning at #EMBLAPhD with SAiGENCIs Lan and Anthony - looking forward to more #AI 🦾🤖 @emblaustralia.org @saigenci.bsky.social @acepigenetics.bsky.social
Congratulations to @saigenci.bsky.social's @aachinger.bsky.social awarded 2025 Sylvia and Charles Viertel Senior Medical Research Fellowship. Dr Achinger-Kawecka leads our 3D Chromatin Organisation Laboratory and receives $1.375m over 5 years to support her work. Read more at bit.ly/3Wva9HH
📣 @saigenci.bsky.social congratulate Professor Jose Polo on his election as Fellow of the Australian Academy of Health & Medical Sciences (AAHMS). Jose is Program Lead for Cancer Epigenetics @SAiGENCI and Director @acepigenetics.bsky.social. Many congratulations Jose! aahms.org/news/29-of-a...
Luke is a group leader at @saigenci.bsky.social & @acepigenetics.bsky.social, within the University of Adelaide. He has extensive expertise in epigenetic regulation and a strong commitment to fostering creative, inclusive science. A perspective we can’t wait to share with our community!
🧵 1/
💗 𝐈𝐭’𝐬 𝐁𝐫𝐞𝐚𝐬𝐭 𝐂𝐚𝐧𝐜𝐞𝐫 𝐀𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬 𝐌𝐨𝐧𝐭𝐡 💗
We’re spotlighting AEpiA member @aachinger.bsky.social (now at @saigenci.bsky.social) and Prof Susan Clark ( @garvaninstitute.bsky.social) for their research on epigenetic therapy in hormone-driven breast cancer.
#BreastCancerAwarenessMonth #AEpiA
📣Congratulations to Professor Brendan Jenkins, @saigenci.bsky.social's Program Lead for Tumour Inflammation and Immunotherapy, on being awarded the Japanese Cancer Association (JCA) International Award. The first Australian recipient! @jenkins-lab.bsky.social 👏
Thank you to the China International Talent Exchange Foundation for hosting our young ACE researchers! We shared our epigenetic research and cutting-edge technologies, whilst learning all about the pioneering research in Harbin, China. A wonderful exchange for ideas!🧪 @saigenci.bsky.social
📣Last night 90+ uni students attended the inaugural "Evening with Cancer Researchers". Hosted by @saigenci.bsky.social with representatives from University of Adelaide, UniSA's CCB and @sahmri.bsky.social. Great to see the enthusiasm of our next gen cancer researchers! @josundstrom.bsky.social 🔬
Welcome new @saigenci.bsky.social PhD students! SAiGENCI student reps Percy Zhang (Polo lab @acepigenetics.bsky.social ) and An Nguen were thrilled to welcome everyone with this warm gathering!
Flyer advertising upcoming webinars. Photos of the speakers are shown on the right. The words read: Dr Stefano Mangiola (SAiGENCI) “Improving the interpretability of AI models for cell biology and precision medicine” Dr Anh TN Nguyen (Monash) “Bridging pharmacology and AI: Accelerating GPCR drug discovery with deep learning” 26 August 2025 12 - 1 pm AEST
Next in our #AI webinars:
Stefano Mangiola @saigenci.bsky.social
talks AI models in #SingleCell and if they can uncover biological patterns
Anh TN Nguyen @monashuniversity.bsky.social shares how deep learning is accelerating #DrugDiscovery for GPCRs
More info www.biocommons.org.au/events/ai-se...
🧬 DNA’s message is only part of the story.
Dr @qizhang85.bsky.social @saigenci.bsky.social is decoding epigenetic modifiers - the hidden editors of gene expression - to uncover new cancer treatments.
🔗 More in our Impact Report: bit.ly/3EVhwD8
#DecodingTheUniverse #ScienceWeek
@saigenci.bsky.social are hiring! Work with our fabulous Group Leader, Dr Luke Isbel and the Molecular Epigenetics Laboratory. Luke is seeking a highly motivated, creative researcher to join his team. See all the details at careers.adelaide.edu.au/cw/en/job/51... @acepigenetics.bsky.social
📣On Friday, @saigenci.bsky.social hosted a delegation from the Chinese biomedical industry as part of the SJTU-AU Innovation Connect 2025 Australia Biomedical Inspection. Thanks to Lan Nguyen, Michael Roy, Fuji Li and Jing Xu representing @saigenci.bsky.social 👏
Join #AI and #Immunology!
📢 Fully funded #PhD @saigenci.bsky.social: develop AI to chart immune diversity across the population, in #cancer.
CV, transcript, and a one-page statement by 30 August 2025 → www.linkedin.com/feed/update/...
#PhDOpportunity #MachineLearning #SingleCell
Huge congrats to the ACE team led by Prof Polo, Dr Sullivan, Dr Bhattacharjee, as well as Prof Lister & Dr Pope on their MRFF Grant, tackling the challenge of helping patients with rare neural diseases! @saigenci.bsky.social @ryanlister.bsky.social @perkinsinstitute.bsky.social tinyurl.com/5t4e9x6n
@saigenci.bsky.social are excited to welcome two new researchers through a fellowship program funded by the Ainsworth Foundation. Dr Georgette Radford and Dr Tamsin Lannagan join the Tumour Inflammation and Immunotherapy program. Read more at www.adelaide.edu.au/newsroom/new... 🔬🧪👏
Great work Team @saigenci.bsky.social raising over $900 for cancer research at today's The Longest Table morning tea. Donations are still rolling in at www.thelongesttable.com.au/fundraisers/... Supporting THRFG. Together let's #forkcancer! 👊
📣 @saigenci.bsky.social thrilled to congratulate Professor Lan Nguyen awarded funding through the ARC's 2025 Future Fellowships scheme for his project "Deciphering contextual multi-pathway crosstalk in cellular decision making". @saigenci.bsky.social's first Future Fellow! bit.ly/4lobxqv 💻🔬👏
👏Congratulations to Dr Mohamed Saad on your @curecancer.bsky.social Researcher of the Year 2025 award. Proud to have you continuing your important work @saigenci.bsky.social! 🧪🔬👊 www.curecancer.com.au/blog/celebra...
📅 SAVE THE DATE - Our much-loved #PhD Course is turning 10!
🧬 This year, our unique, two-week course will be held at SAiGENCI & focus on #AI in #biology.
👉 For more info, to have your say on course content or to sponsor the event, visit our website: bit.ly/3GNpEpF
Updated results from Australian-led ENZAMET trial highlighting long-term outcomes with XTANDI® in mHSPC to be presented at #ASCO25. @saigenci.bsky.social Director @chrissweens1.bsky.social key leader in the ENZAMET study. Check out the full story at oncologynews.com.au/latest-news/...